Clinical Trials Browser

INDUSTRY × Colorectal Neoplasms × Dabigatran × Clear all

NCT05368805 2022-10-06

Fruquintinib DDI Study With P-gp and BCRP Substrates

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms